These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26088116)

  • 81. Preclinical and clinical studies with somatostatin related to the central nervous system.
    Vécsei L; Widerlöv E
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(4):473-502. PubMed ID: 1978375
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Flying fitness of patients with neurologic diseases--aircraft travel and the central nervous system].
    Schmutzhard E
    Wien Med Wochenschr; 2002; 152(17-18):466-8. PubMed ID: 12385070
    [TBL] [Abstract][Full Text] [Related]  

  • 83. D-serine regulation: a possible therapeutic approach for central nervous diseases and chronic pain.
    Sethuraman R; Lee TL; Tachibana S
    Mini Rev Med Chem; 2009 Jun; 9(7):813-9. PubMed ID: 19519506
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Selection criteria for neurophysiologic biomarkers to accelerate the pace of CNS therapeutic development.
    Light GA; Swerdlow NR
    Neuropsychopharmacology; 2020 Jan; 45(1):237-238. PubMed ID: 31506611
    [No Abstract]   [Full Text] [Related]  

  • 85. New era for novel CNS drug development.
    Potter WZ
    Neuropsychopharmacology; 2012 Jan; 37(1):278-80. PubMed ID: 22157855
    [No Abstract]   [Full Text] [Related]  

  • 86. The future of neuroimmunology research for CNS disease therapeutics.
    Lambris JD; Rosenthal A; Pelegrín P; Tremblay MÈ; Chen P
    Trends Pharmacol Sci; 2022 Aug; 43(8):611-614. PubMed ID: 35839748
    [No Abstract]   [Full Text] [Related]  

  • 87. Central Disorders of Hypersomnolence: Focus on the Narcolepsies and Idiopathic Hypersomnia.
    Khan Z; Trotti LM
    Chest; 2015 Jul; 148(1):262-273. PubMed ID: 26149554
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Adverse Events Associated with Flumazenil Treatment for the Management of Suspected Benzodiazepine Intoxication--A Systematic Review with Meta-Analyses of Randomised Trials.
    Penninga EI; Graudal N; Ladekarl MB; Jürgens G
    Basic Clin Pharmacol Toxicol; 2016 Jan; 118(1):37-44. PubMed ID: 26096314
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Clarithromycin in γ-aminobutyric acid-Related hypersomnolence: A randomized, crossover trial.
    Trotti LM; Saini P; Bliwise DL; Freeman AA; Jenkins A; Rye DB
    Ann Neurol; 2015 Sep; 78(3):454-65. PubMed ID: 26094838
    [TBL] [Abstract][Full Text] [Related]  

  • 90. TGF-β/Smad3 Signalling Modulates GABA Neurotransmission: Implications in Parkinson's Disease.
    Muñoz MD; de la Fuente N; Sánchez-Capelo A
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963327
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Trigeminal neuropathic pain development and maintenance in rats are suppressed by a positive modulator of α6 GABA
    Vasović D; Divović B; Treven M; Knutson DE; Steudle F; Scholze P; Obradović A; Fabjan J; Brković B; Sieghart W; Ernst M; Cook JM; Savić MM
    Eur J Pain; 2019 May; 23(5):973-984. PubMed ID: 30633839
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Flumazenil for the Treatment of Refractory Hypersomnolence: Clinical Experience with 153 Patients.
    Trotti LM; Saini P; Koola C; LaBarbera V; Bliwise DL; Rye DB
    J Clin Sleep Med; 2016 Oct; 12(10):1389-1394. PubMed ID: 27568889
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Off-Label Use of Medications for Treatment of Benzodiazepine Use Disorder.
    Sabioni P; Bertram J; Le Foll B
    Curr Pharm Des; 2015; 21(23):3306-10. PubMed ID: 26088120
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The role of flumazenil in the critically ill.
    Park GR; Navapurkar V; Ferenci P
    Acta Anaesthesiol Scand Suppl; 1995; 108():23-34. PubMed ID: 8693921
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Hepatic encephalopathy and role of antibenzodiazepines.
    Hammond JB; Ahmad F
    Am J Ther; 1998 Jan; 5(1):33-6. PubMed ID: 10099035
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Flumazenil, a GABA antagonist, may improve features of Parkinson's disease.
    Ondo WG; Hunter C
    Mov Disord; 2003 Jun; 18(6):683-5. PubMed ID: 12784272
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Novel Indications for Benzodiazepine Antagonist Flumazenil in GABA Mediated Pathological Conditions of the Central Nervous System.
    Hulse G; Kelty E; Hood S; Norman A; Basso MR; Reece AS
    Curr Pharm Des; 2015; 21(23):3325-42. PubMed ID: 26088116
    [TBL] [Abstract][Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.